Jim DeTore

Jim DeTore

Chief Financial OfficeratCG Oncology· In the 2025 proxy

Pay in FY2025CG Oncology stock +44.8% the same year

Jim DeTore was paid $96.0K in FY2025 (Dec). CG Oncology stock rose 44.8% that year.

Pay$100 in the stock at the end of FY24 → $145
Pay is from the Summary Compensation Table of each CG Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CG OncologyPublic company · 1 yr
    • Chief Financial Officer2025 – Present · 1 yrStock in role +126%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?